Functional Brands Inc. (NASDAQ:MEHA – Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totaling 638,792 shares, a decrease of 37.9% from the April 30th total of 1,028,286 shares. Based on an average trading volume of 93,845,172 shares, the days-to-cover ratio is currently 0.0 days. Currently, 2.9% of the company’s stock are sold short.
Functional Brands Price Performance
NASDAQ:MEHA opened at $0.09 on Friday. The stock has a market capitalization of $1.92 million and a price-to-earnings ratio of -0.27. The company has a fifty day simple moving average of $0.12. The company has a quick ratio of 0.64, a current ratio of 1.20 and a debt-to-equity ratio of 0.25. Functional Brands has a 12 month low of $0.06 and a 12 month high of $8.00.
Functional Brands (NASDAQ:MEHA – Get Free Report) last posted its earnings results on Friday, May 15th. The company reported ($0.36) EPS for the quarter. The company had revenue of $1.65 million during the quarter.
Analyst Ratings Changes
Check Out Our Latest Analysis on Functional Brands
Hedge Funds Weigh In On Functional Brands
A hedge fund recently bought a new stake in Functional Brands stock. Jane Street Group LLC acquired a new stake in Functional Brands Inc. (NASDAQ:MEHA – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 194,968 shares of the company’s stock, valued at approximately $37,000. Jane Street Group LLC owned approximately 1.19% of Functional Brands at the end of the most recent reporting period.
About Functional Brands
Our company operates in the nutraceutical supplement industry. We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales. Our products are sold over the counter, and consumers do not need a prescription to purchase our products.
See Also
- Five stocks we like better than Functional Brands
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Functional Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Functional Brands and related companies with MarketBeat.com's FREE daily email newsletter.
